In triple-negative breast cancers (TNBCs), TRIM21 knockdown could stabilize CD73 protein and promote CD73-mediated adenosine accumulation, dampening CD8+ T cell function. The gene discussed is NT5E; the disease is triple-negative breast carcinoma.